PRIMARY BILIARY-CIRRHOSIS

被引：14

作者：

LAURIN, JM

LINDOR, KD

机构：

[1] Division of Gastroenterology, Mayo Clinic and Foundation, Rochester, MN

来源：

DIGESTIVE DISEASES | 1994年 / 12卷 / 06期

关键词：

PRIMARY BILIARY CIRRHOSIS; PYRUVATE DEHYDROGENASE COMPLEX; AUTOIMMUNE DISORDERS; URSODEOXYCHOLIC;

D O I：

10.1159/000171469

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Primary biliary cirrhosis is a chronic, usually progressive, cholestatic liver disease of presumed autoimmune etiology that affects predominantly young and middle-aged women. It is nearly always associated with an antibody directed against a component of the pyruvate dehydrogenase complex located on the inner wall of the mitochondria. The disease is associated with a number of other associated autoimmune disorders. No totally effective medic;ll treatment has been established for the disease, although ursodeoxycholic acid appears promising. Complications of cholestasis such as fat malabsorption and fat-soluble vitamin deficiency should be excluded or corrected when found. Individual patient prognosis varies. Several models for estimating individual patient survival are available. Liver transplantation is recognized as a procedure to extend and improve the quality of life for patients with advanced disease.

引用

页码：331 / 350

页数：20

共 132 条

[41]

Hashimoto E., Lindor K.D., Homburger H.A., Dickson E.R., Czaja A.J., Wiesner R.H., Ludwig J., Immunohis-tochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis, Mayo Clin Proc, 68, pp. 1049-1055, (1993)

[42]

Adams D.H., Hubscher S.G., Shaw J., Johnson G.D., Babbs C., Rothlein R., Ncubcrger J.M., Increased expression of intracellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis, Hepatology, 14, pp. 426-431, (1991)

[43]

Ballardini G., Mirakian R., Bianchi F.B., Pisi E., Doniach D., Bottazzo G.F., Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: Relevance to pathogenesis, Lancet, 2, pp. 1009-1013, (1984)

[44]

Nakanuma Y., Kono N., Expression of HLA-DR antigens on interlobular bile ducts in primary biliary cirrhosis and other hepatobiliary diseases: An immunohistochcmical study, Hum Pathol, 22, pp. 431-436, (1991)

[45]

Nouri-Aria K.T., Lombard M., Williams R., High serum levels of CD8 antigen in primary' biliary cirrhosis: A possible cause of suppressor cell dysfunction?, Clin Exp Immunol, 86, pp. 140-144, (1991)

[46]

Nakanuma Y., Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis, Hepatology, 18, pp. 570-575, (1993)

[47]

Crowe J.P., Christensen E., Butler J., Wheeler P., Doniach D., Keenan J., Williams R., Primary biliary cirrhosis: The prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome, Gastroenterology, 78, pp. 1437-1441, (1980)

[48]

Murrav-Lyon I.M., Thompson R., Ansell I.D., Williams R., Scleroderma and primary biliary cirrhosis, Br Med J, 1, pp. 258-259, (1970)

[49]

Clarke A.K., Galbraith R.M., Hamilton E., Williams R., Rheumatic disorders in primary biliary cirrhosis, Ann Rheum Dis, 37, pp. 42-47, (1978)

[50]

Uddenfeldt P., Danielsson A., Forssell A., Holm M., Ostbcrg Y., Features of Sjorgren's syndrome in patients with primary biliary cirrhosis, J Intern Med, 230, pp. 443-448, (1991)

← 1 2 3 4 5 6 7 8 9 10 →